GV20 Oncotherapy
Latest round
- Series B
Last raised
- Oct 2021
Total raised
- Undisclosed
Investors
- 7
About GV20 Oncotherapy
Established in 2016 and based in Shanghai, China, GV20 Oncotherapy is a company that focuses on selecting effective targets cancer drugs. It also develops approached to cancer diagnosis and therapy. The company mainly involved in the field of gene editing library screening, bioinformatics and big data analysis. The company main business is technology consulting, technology development, technology services, technology transfer in the fields of biotechnology and medical technology. The company have self developed GV20 unique platforms, GV20 genomics platform and GV20 AI (artificial intelligence) platform that provides a portfolio of immuno-oncology antibody drug solution for customers.
Who invested in GV20 Oncotherapy
7 investors across 3 rounds
See all investors in GV20 Oncotherapy
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GV20 Oncotherapy
Who invested in GV20 Oncotherapy?
GV20 Oncotherapy has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GV20 Oncotherapy raised?
GV20 Oncotherapy has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did GV20 Oncotherapy last raise money?
GV20 Oncotherapy's most recent round on record is a Series B, in Oct 2021.
What does GV20 Oncotherapy do?
Established in 2016 and based in Shanghai, China, GV20 Oncotherapy is a company that focuses on selecting effective targets cancer drugs.
Where is GV20 Oncotherapy headquartered?
GV20 Oncotherapy is headquartered in Shanghai, China.
Which VCs invest in companies like GV20 Oncotherapy?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare specialists companies at GV20 Oncotherapy's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like GV20 Oncotherapy? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.